Given Imaging Ltd. (GIVN) Announces Data Confirming PillCam® SB Improves Monitoring and Management of Crohn's Disease
5/21/2013 9:23:38 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ORLANDO, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced new studies that confirm the value of PillCam SB in diagnosing, monitoring and managing patients with known or suspected Crohn's disease and other conditions of the small bowel. The studies were presented at Digestive Disease Week® (DDW), taking place May 18-21, 2013, at the Orange County Convention Center, Orlando, FL, where Given Imaging is exhibiting at booth #1059 throughout the conference.
Help employers find you! Check out all the jobs and post your resume.
comments powered by